Metsä Board Shows Cartonboards Designed for Healthcare at Pharmapack 2014, Stand 654
Share:
Metsä Board, Europe's leading producer of fresh forest fibre cartonboards, is showing its folding boxboards especially designed for healthcare at Pharmapack 2014 in Paris - the first time it has exhibited at the show. With high brightness, excellent hygiene properties and light weight but strong, Metsä Board's cartonboards are ideal for both prescription and OTC products, and have a surface developed for special effects that include, for example, 2D data matrix coding and Braille.
The Metsä Board range of cartonboards for pharmaceutical applications includes Carta Solida, Carta Elega, Avanta Prima and Simcote. They are made from fibres grown in sustainably managed Nordic forests, are of known origin and traceable. Fresh forest fibres are strong, pure and contribute to the excellent brightness of the cartonboards.
"With our boards you can produce more cartons per tonne, as they have a significant yield advantage over competitive products," says Christophe Baudry, Commercial Director Beautycare & Healthcare, Metsä Board. "We've achieved this by light-weighting our boards, but without losing strength or stiffness. And as they use fewer raw materials, need less processing and energy throughout the value chain, they offer considerable sustainability benefits."
Metsä Board's cartonboards offer dust-free printing due to excellent sheet-cutting qualities, and give uniform print results and visual appearance thanks to high brightness and shade consistency.
Recent improvements to the range have brought many benefits. The shade of Carta Elega and Avanta Prima has been optimised to enhance visual whiteness - an important characteristic in the healthcare market. White areas appear cleaner and brighter, giving more shelf appeal. Carta Elega is particularly suitable for special features such as foil lamination, hot foil stamping and embossing. The surface of Avanta Prima has been optimized for the use of 2D data matrix coding.
The bulk of Simcote and Avanta Prima has been improved, meaning a lighter weight can be specified whilst maintaining the same thickness and stiffness. As a result, grammages have been light-weighted across the range, providing both cost and sustainability benefits.
For further information, please contact Metsä Board:
Christophe Baudry
Commercial Director Beautycare & Healthcare
Mobile: +33674951598
E-mail: christophe.baudry@metsagroup.com
www.metsaboard.com
Metsä Board is Europe's leading producer of fresh forest fibre cartonboards, the world's leading manufacturer of coated white-top kraftliners, and a major paper supplier. The company's sales network serves brand owners, carton printers, corrugated packaging manufacturers, printers, merchants and office suppliers.
Metsä Board supports its customers' businesses by providing high-performance paperboards and quality papers for consumer and retail packaging, graphics and office end-uses. Together with its customers and partners, Metsä Board develops products and services for demanding end uses. The company's paperboard is mainly used for the packaging of beautycare and healthcare products, foods, cigarettes, and consumer durables as well as graphics. Paper is mainly used for office papers as well as wallcoverings and other speciality end uses.
Metsä Board's business areas are Cartonboard, and Linerboard and Paper.
Metsä Board is headquartered in Finland. In 2013, the company's sales totalled EUR 2.0 billion, and it has approximately 3,100 employees. Metsä Board, part of Metsä Group, is listed on the NASDAQ OMX Helsinki.
www.metsagroup.com
Metsä Group is a responsible forest industry group whose products are part of people's everyday life and promote sustainable well-being. Metsä Group produces high-quality products mainly from renewable Nordic wood. The Group's business areas are tissue and cooking papers, board and paper, pulp, wood products as well as wood supply. Metsä Group's sales totalled EUR 4.9 billion in 2013, and it employs approximately 10,700 people. The Group is present in some 30 countries.
